Cargando…

Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort

BACKGROUND: It is widely accepted that metabolic syndrome is associated with an increased risk of chronic kidney disease (CKD). To investigate whether coexisting metabolic syndrome is a necessary condition for CKD in overweight and obese. METHODS: A cohort study of 6852 Chinese individuals from Augu...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Xia, Zhou, Jiansong, Yuan, Hong, Wu, Liuxin, Chen, Zhiheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471928/
https://www.ncbi.nlm.nih.gov/pubmed/26084279
http://dx.doi.org/10.1186/s12882-015-0083-8
Descripción
Sumario:BACKGROUND: It is widely accepted that metabolic syndrome is associated with an increased risk of chronic kidney disease (CKD). To investigate whether coexisting metabolic syndrome is a necessary condition for CKD in overweight and obese. METHODS: A cohort study of 6852 Chinese individuals from August 2007 to December 2012. Examinations included a questionnaire, physical measurements, and blood sampling. Hazard ratios for incident CKD were estimated according to combinations of BMI category and absence or presence of metabolic syndrome. RESULTS: For CKD, multivariable adjusted hazard ratios vs. normal weight individuals without metabolic syndrome were 1.31 (95 % CI, 0.89–1.92) in overweight and 2.39 (95 % CI, 1.27–4.52) in obese without metabolic syndrome and 1.54 (95 % CI, 1.18–3.95) in normal weight, 2.06 (95 % CI, 1.27–3.36) in overweight, and 2.77 (95 % CI, 1.42–4.31) in obese with metabolic syndrome. There were no interactions between BMI and absence or presence of metabolic syndrome on risk of CKD when BMI was categorized (normal weight, overweight, obese) (P = 0.17). Among individuals both with and without metabolic syndrome there were increasing cumulative incidences of CKD from normal weight through overweight to obese individuals (log-rank trend P = 0.04 to P < 0.001). Although the multivariable adjusted hazard ratio for CKD in individuals with vs. without metabolic syndrome was 1.82 (95 % CI, 1.20–2.78) within overweight and obese individuals (log-rank P = 0.005), only 26.1 % of the increased risk observed for BMI is explained by metabolic syndrome. CONCLUSIONS: These findings suggest overweight and obesity are risk factors for CKD regardless of the presence or absence of metabolic syndrome. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12882-015-0083-8) contains supplementary material, which is available to authorized users.